MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$163,055,000
(1009.40%↑ Y/Y)
Change in contingent
consideration
-$6,501,000
Interest expense
$2,782,000
(7541.81%↑ Y/Y)
Foreign exchange
transaction loss
-$52,000
(-68.90%↓ Y/Y)
Net income (loss)
before income taxes
$150,016,000
(876.29%↑ Y/Y)
Income tax (benefit)
-$13,039,000
(-834.85%↓ Y/Y)
Total other income
(expense)
-$125,000
(-104.12%↓ Y/Y)
General and
administrative
$68,220,000
(127.71%↑ Y/Y)
Selling and marketing
$38,054,000
(32.42%↑ Y/Y)
Research and development
$19,333,000
(390.40%↑ Y/Y)
Unrealized gain on
marketable security
$5,364,000
Interest income
$3,846,000
(49.14%↑ Y/Y)
Income (loss) from
operations
$150,141,000
Total operating
expenses
$125,607,000
(100.53%↑ Y/Y)
Gross profit
$275,748,000
(584.55%↑ Y/Y)
Total revenues
$311,709,000
(617.03%↑ Y/Y)
Total revenues
$311,709,000
(617.03%↑ Y/Y)
Total revenues
$311,709,000
(617.03%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
CorMedix Inc. (CRMD)
CorMedix Inc. (CRMD)